Literature DB >> 1873267

Eyedrop instillation for reluctant children.

S E Smith1.   

Abstract

Pupillary responses to pilocarpine eyedrops applied by different techniques have been studied in healthy volunteer subjects. In particular a novel method was evaluated in which eyedrops were applied to the inner canthus with eyes tightly closed and the subject supine, followed immediately by opening of the eyes. The response to this technique indicates that drug penetration into the eye was 66% (confidence intervals 28 to 104%) of that obtained by conventional instillation, into the conjunctival sac, with or without 2 min pressure on the inner canthus. This method of instillation, which is free of aggravation, may be clinically useful for patients, especially children, unwilling or unable to tolerate conventional instillation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1873267      PMCID: PMC1042436          DOI: 10.1136/bjo.75.8.480

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Extraocular fluid dynamics: how best to apply topical ocular medication.

Authors:  F T Fraunfelder
Journal:  Trans Am Ophthalmol Soc       Date:  1976

2.  Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations.

Authors:  J A Kelly; P D Molyneux; S A Smith; S E Smith
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

3.  An increased effect of pilocarpine on the pupil by application of the drug in oil.

Authors:  S A Smith; S E Smith; R Lazare
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

4.  Improving the therapeutic index of topically applied ocular drugs.

Authors:  T J Zimmerman; K S Kooner; A S Kandarakis; L P Ziegler
Journal:  Arch Ophthalmol       Date:  1984-04
  4 in total
  1 in total

1.  Application of eye drops to the medial canthus.

Authors:  A Loewenstein; S Bolocinic; M Goldstein; M Lazar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-11       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.